This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
Journal of Hematology & Oncology Open Access 03 July 2017
-
Targeting p53 by small molecules in hematological malignancies
Journal of Hematology & Oncology Open Access 27 March 2013
-
XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells
Journal of Experimental & Clinical Cancer Research Open Access 11 December 2010
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fong WG, Liston P, Rajcan-Separovic E, St Jean M, Craig C, Korneluk RG . Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 2000; 70: 113–122.
Plenchette S, Cheung HH, Fong WG, LaCasse EC, Korneluk RG . The role of XAF1 in cancer. Curr Opin Invest Drugs 2007; 8: 469–476.
Ghia P, Ferreri AM, Caligaris-Cappio F . Chronic lymphocytic leukemia. Crit Rev Oncol Hematol 2007; 64: 234–246.
Secchiero P, di Iasio MG, Gonelli A, Zauli G . The MDM2 inhibitors Nutlins as an innovative therapeutic tool for the treatment of hematological malignancies. Curr Pharm Des 2008; 14: 2100–2110.
Zenz T, Kröber A, Scherer K, Häbe S, Bühler A, Benner A et al. Mono-allelic TP53 inactivation is associated with poor prognosis in CLL: results from a detailed genetic characterization with long term follow-up. Blood 2008; 112: 3322–3329.
Arora V, Cheung HH, Plenchette S, Micali OC, Liston P, Korneluk RG . Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex. J Biol Chem 2007; 282: 26202–26209.
Steele AJ, Prentice AG, Hoffbrand AV, Yogashangary BC, Hart SM, Lowdell MW et al. p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism. Blood 2008; 112: 3827–3834.
Wang J, He H, Yu L, Xia HH, Lin MC, Gu Q et al. HSF1 down-regulates XAF1 through transcriptional regulation. J Biol Chem 2006; 281: 2451–2459.
Acknowledgements
This study was supported by grants from the Italian Association for Cancer Research (AIRC) and Beneficientia Foundation (both to GZ).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Secchiero, P., di Iasio, M., Melloni, E. et al. The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia. Leukemia 24, 480–483 (2010). https://doi.org/10.1038/leu.2009.215
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2009.215
This article is cited by
-
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
Journal of Hematology & Oncology (2017)
-
Targeting p53 by small molecules in hematological malignancies
Journal of Hematology & Oncology (2013)
-
XAF1 expression and regulatory effects of somatostatin on XAF1 in prostate cancer cells
Journal of Experimental & Clinical Cancer Research (2010)